Osthole inhibits GSK-3β/AMPK/mTOR pathway-controlled glycolysis and increases radiosensitivity of subcutaneous transplanted hepatocellular carcinoma in nude mice

Strahlenther Onkol. 2024 May;200(5):444-452. doi: 10.1007/s00066-023-02173-8. Epub 2023 Nov 14.

Abstract

Purpose: Osthole possesses anti-tumor activities. However, whether osthole can have a radiosensitization effect on hepatic cancer remains unclear. Here, an HCC-LM3 cells-inoculated subcutaneous transplanted tumor was adopted to explore the effect of osthole.

Methods: The tumor-bearing mice were treated with 100 mg/kg osthole for 12 days, 4 Gy irradiation twice, or their combination. The tumor volume and weight, lactic acid content, glycolytic enzyme activities, and protein expression of glycogen synthase kinase 3β (GSK-3β), p‑GSK-3β, mammalian target of rapamycin (mTOR), p‑mTOR, AMP-activated protein kinase (AMPK), p‑AMPK, glucose transporter 1/3, and pyruvate kinase M2 were determined. The GSK-3β-overexpressed HCC-LM3 or SK-Hep‑1 cell models were also adopted to verify the effects of osthole on expression of these proteins.

Results: The tumor volume and weight, lactic acid content, and glycolytic enzyme activities in tumor tissues were lower in the osthole + radiation group than in the radiation group. Moreover, osthole could reverse the radiation-induced increments of p‑GSK-3β/GSK-3β and p‑mTOR/mTOR protein ratios and the expression of glucose transporter 1/3 and pyruvate kinase M2 proteins in tumor tissues, and increase the protein ratio of p‑AMPK/AMPK. The effects of osthole on these glycolysis-related proteins were also observed in GSK-3β-overexpressed HCC-LM3 or SK-Hep‑1 cell models.

Conclusion: Osthole has a radiosensitizing effect on subcutaneous transplanted hepatocellular carcinoma, and its mechanism may be related to inhibition of GSK-3β/AMPK/mTOR pathway-controlled glycolysis.

Keywords: Glucose metabolism; Glycogen synthase kinase-3β; Hepatic cancer; Natural product; Radiosensitization.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • AMP-Activated Protein Kinases* / metabolism
  • Animals
  • Carcinoma, Hepatocellular / drug therapy
  • Carcinoma, Hepatocellular / pathology
  • Cell Line, Tumor
  • Coumarins* / pharmacology
  • Glycogen Synthase Kinase 3 beta* / metabolism
  • Glycolysis* / drug effects
  • Glycolysis* / radiation effects
  • Humans
  • Liver Neoplasms / drug therapy
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Mice, Nude*
  • Radiation Tolerance* / drug effects
  • Radiation-Sensitizing Agents / pharmacology
  • Signal Transduction* / drug effects
  • TOR Serine-Threonine Kinases* / metabolism

Substances

  • Coumarins
  • TOR Serine-Threonine Kinases
  • osthol
  • Glycogen Synthase Kinase 3 beta
  • AMP-Activated Protein Kinases
  • Radiation-Sensitizing Agents
  • mTOR protein, mouse